Marwynn Holdings, Inc.

MWYN
About the company

Marwynn Holdings, Inc. engages in the supply chain business in the United States. It operates through sale of food and beverage; consulting services; and sale of e-waste materials segments. The company offers frozen food, snacks, dry groceries, seasonings, and non-alcoholic beverages to markets, grocery stores, and wholesale/warehouse clubs; and kitchen cabinets, flooring, and home improvement products. It also provides supply chain consulting and market expansion support services.

Country: United StatesPrice: $1.29Market Cap: $31.2M

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

1 / 15

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Buffett, Lynch +1 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2564 (Top 82.8%)FAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Annual history · FY 2025

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-07-31 · TTM ended 2026-07-31

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-07-31

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-03-01–2026-11-01 · Balance sheet at 2026-07-31

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-07-30

Score computed: 2026-11-14

TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Price history 2025-03-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-07-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-07-31

Latest source filing: 2026-09-14

Score computed: 2026-11-14

TTM ended 2026-07-31 · Annual history · FY 2025 · Price history 2025-03-01–2026-11-01

Latest source filing: 2026-09-14

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Buffett, Lynch +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest Coverage
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.06
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities4.94
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.06
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.06
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-643.5x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.06
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0599; #1073/4210 (top 25.5%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 1✗ 34▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)1/4 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)1/4 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-68.3%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-4.4M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-52.3%
    ✗Lynch> 15%
    EBIT / Enterprise Value-10.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-10.6%, ROC=-142.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-130.22%
    ✗PiotroskiROA > 0
    ROA Change YoY-29.45% -> -130.22% (delta: -100.77%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-51.40%, ROA=-130.22%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY46.7% -> 15.3%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-12.4%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-52.3%
    ✗Dreman> 12%
    Margin of SafetyP/B=10.1x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-68.3% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency1/3 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-13.8%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-52.3%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend11.7% (2023) -> -77.3% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 44.8% -> 15.3%, operating margin 11.7% -> -77.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-4.19%; #3797/6340 (top 59.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+27.17%; #1581/3702 (top 42.7%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-52.31%; #4230/5226 (top 80.9%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.5835; #5034/5884 (top 85.6%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 1✗ 27▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio10.1x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-10.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-10.6%, ROC=-142.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share10.1x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-14.8%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=10.1x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low221% of trailing low ($0.58)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-4.19%; #3797/6340 (top 59.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.0802; #4859/6449 (top 75.3%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share10.61x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.1696; #3933/5247 (top 75.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+90.32%; #375/6202 (top 6.0%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✓ 1✗ 11▾

    No clean pass — all 10 investors flag at least one cash flow criterion

    Free Cash Flow Proxy$-4.4M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-5.3M
    ✗LynchPositive and growing
    Operating Cash Flow$-1.5M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-51.40%, ROA=-130.22%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive1/2 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency1/3 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 1✗ 12▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue Growth
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$0.07 (2023) -> $-0.21 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency1/3 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth167.1%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency1/2 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 44.8% -> 15.3%, operating margin 11.7% -> -77.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts0% pass✗ 16▾

    Split decision: 15 FAIL · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)✗GreenblattRank #2564✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (2/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #1556/2370 (Top 65.7%))✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency25% pass✓ 3✗ 8▾

    6 of 8 flag MWYN's efficiency — Buffett, Greenblatt, Piotroski +3 more

    Current Ratio4.94
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-13.8%
    ✗Buffett> 10%
    ROIC - WACC-23.8%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-142.4%
    ✗Greenblatt> 25%
    Current Ratio Change YoY17.04 -> 6.73
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.05x -> 1.41x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities4.94
    ✓Dreman> 1.5
    Return on Invested Capital-21.8%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=32.1%; FY2024: ROIC=-67.2%; FY2025: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)1/2 years above 12% (latest -67.2%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Wholesale
SIC Sector: Nondurable Goods Wholesale
Size: Micro Cap($31.2M)
Revenue: $4.2M+427.5% YoY
Net Income: $3.9M+10.9% YoY

Financial Snapshot

Operating Margin-77.3%
Return on Equity-151.8%
Debt / Equity--
Current Ratio6.73
EPS (Diluted)$-0.21
Shares Retired−18.4% / −34.6% 2y

Similar Companies

MCKMCKESSON CORP
$127.3B
GWWW.W. GRAINGER, INC.
$69.7B
CAHCARDINAL HEALTH INC
$65.0B
SYYSYSCO CORP
$38.0B

Shareholder Return

Fiscal 2025

Issued 18.4% of shares last year, 34.6% issued over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-07-31

2025-08-01 – 2026-07-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, revenue, net income, operating income, gross profit, ebit, pre tax income.

Q1 FY 2027

2026-05-01 – 2026-07-31

Sources
FY 2025
Sources
  • 10-K · 2026-07-30
FY 2024
Sources
  • 10-K · 2025-08-08
FY 2023
Sources
  • 10-K · 2025-08-08
FY 2022
Sources
  • 10-K · 2025-08-08
Market Cap$31.2Mcurrent--$16.3Mest.$71.1Mest.----
Revenue$5.3M$1.1M↓53%$4.2M↑428%$804.3K↓93%$11.9M--
Operating Income-$730.8K-$84.1K↑97%-$3.3M↑25%-$4.4M↓413%$1.4M--
Net Income-$1.3M-$108.9K↑96%-$3.9M↑11%-$4.4M↓541%$998.1K--
EPS (Diluted)--$-0.01↑97%$-0.21↑28%$-0.29↓514%$0.07--
Gross Margin16.0%21.6%↓49%15.3%↓67%46.7%↑4%44.8%—
Operating Margin-13.8%-7.7%↑93%-77.3%↑86%-541.3%↓4741%11.7%—
ROE-52.3%—-151.8%↓72%-88.5%↓350%35.4%—
Total Debt$150.0K$150.0K↑15%--$145.9K↓76%$600.0K--
Shareholders' Equity$2.5M$2.5M↑10%$2.6M↓48%$5.0M↑76%$2.8M↑1163%$223.3K
Current Ratio4.944.94↑330%6.73↓61%17.04↑1274%1.24—
Debt / Equity0.060.06↑4%—0.03↓86%0.21—
Operating Cash Flow-$1.8M-$327.6K↓244%-$1.5M↑71%-$5.3M↓603%$1.0M--
Free Cash Flow---$328.7K---$5.3M↓674%$920.9K--

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Wholesale

MWYN vs Peers — Financial Grading

Revenue$4.2MBottom 25%
Net Income$3.9MBottom 25%
ROE-151.8%Bottom 25%
D/E—
Op. Margin-77.3%Bottom 25%
Curr. Ratio6.73Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
MCKESSON CORPMCK$127.3B$1102.81$403.4B$4.8B-219.2%-3.001.5%0.852/95/94/70/3F-Score 61/11
W.W. GRAINGER, INC.GWW$69.7B$1489.30$17.9B$1.7B45.7%0.6713.9%2.834/96/94/71/3F-Score 65/11
CARDINAL HEALTH INCCAH$65.0B$281.10$254.2B$1.7B-59.5%-3.081.0%0.882/93/93/70/3F-Score 81/11
SYSCO CORPSYY$38.0B$77.10$81.4B$1.8B99.9%—3.8%1.213/95/95/71/3F-Score 42/11
RELIANCE, INC.RS$21.8B$427.33$14.3B$739.4M10.3%0.207.1%4.884/97/93/70/3F-Score 55/11
WATSCO INCWSO$12.8B$308.46$7.2B$497.0M17.9%0.1710.0%4.125/97/94/71/3F-Score 68/11
APPLIED INDUSTRIAL TECHNOLOGIES INCAIT$10.9B$297.60$4.6B$393.0M21.3%0.3110.9%3.326/95/94/71/3F-Score 57/11
POOL CORPPOOL$7.7B$216.20$5.3B$406.4M34.3%1.0111.0%2.243/96/94/71/3F-Score 56/11